| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5537365 | Vaccine | 2016 | 6 Pages |
Abstract
Administration of CD-JEV to these children with pre-existing neutralizing JE antibody titers was safe and resulted in substantial boosting of antibody levels. These results may inform other countries in Asia considering switching from IMBV to now WHO-prequalified CD-JEV vaccine to combat this disease of public health importance.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Pushpa Ranjan Wijesinghe, M.R. Nihal Abeysinghe, Sutee Yoksan, Yafu Yao, Benli Zhou, Lei Zhang, Jessica A. Fleming, Anthony A. Marfin, John C. Victor,